Celiac Disease News and Research

Latest Celiac Disease News and Research

Gluten, lactose, food dyes in pills could be causing side effects finds study

Pills or oral medications contain inactive ingredients. Some of these may be responsible for the side effects says a new study. The study results appeared in an article published in the latest issue of the journal Science Translational Medicine.

18 Mar 2019

Fecal transplantation improves the gut of IBS patients

Transplantation of feces from a healthy person to a patient suffering of irritable bowel syndrome improved both symptoms of IBS and the gut's bacteria profile.

7 Mar 2019

Celiac disease may be caused by gastrointestinal infection in childhood

A new study has found that a childhood stomach bug may be the cause of celiac disease later in life. The findings could pave the way for a vaccine to protect against the disease.

15 Feb 2019

Gluten-free wheat can be produced for people with celiac disease by using gene editing

One to two per cent of the population has Celiac Disease (CD), an immune reaction to gluten. Wheat grains contain gluten, a mixture of glutenin and gliadin proteins, which build a network that gives wheat bread its unique properties and quality.

28 Jan 2019

Common food additive could cause celiac disease, review says

Research suggests that celiac disease could be caused by a bacterial enzyme used to manufacture sausages, cheese, bread and other processed foods.

7 Jan 2019

Study follows children into adolescence to more accurately assess type 1 diabetes risk

Scientists are narrowing in on checklists of both errant genes and the environmental factors that could trigger those genes to more accurately assess type 1 diabetes risk and help children and their families avoid it.

3 Jan 2019

World’s first vaccine against coeliac disease to be tested in Australia

US-based pharmaceutical company ImmusanT, after worldwide trials, is all set to start clinical trials of a new vaccine against coeliac disease at the Royal Melbourne Hospital Clinical Trials Centre in Melbourne. This will be followed by trials to be held at Adelaide, Brisbane, Perth, Mackay and Sunshine Coast say the sources.

31 Oct 2018

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.

22 Oct 2018

Researchers study how proliferation of gluten-free industry affects people with celiac disease

A new Journal of Human Nutrition and Dietetics study has investigated how the recent proliferation of the gluten-free industry has affected individuals living with celiac disease.

3 Oct 2018

TU Wien develops new remedy for celiac disease

Celiac disease is a fairly common disease, affecting one to two percent of the European population. It is expressed as a hypersensitivity to gluten, a protein found in cereals such as wheat, barley or rye.

24 Sep 2018

UGR to coordinate the European H2020 project focused on Smart Personalized Nutrition

The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.

19 Sep 2018

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy™ platform to translate and deliver first-in-class peptide-based immune therapies to people living with autoimmune diseases, today announced that it has received an investment from the JDRF T1D Fund, a venture philanthropy fund exclusively devoted to finding and funding the best type 1 diabetes commercial opportunities.

11 Sep 2018

Major pitfall identified in popular prostate cancer PET imaging method

Prostate-specific membrane antigen positron emission tomography imaging has become a popular method for determining the stage of a patient's prostate cancer.

7 Sep 2018

Research identifies cell signaling pathways related to endocannabinoid system in worms

Like mammals, parasitic worms have an endocannabinoid system that may help the worm and the hosts it infects survive by reducing pain and inflammation in the host, according to a "wild" new discovery by an interdisciplinary research team at the University of California, Riverside.

23 Aug 2018

Researchers identify role of infection-fighting cells in inflamed and damaged tissue

Hookworms infect nearly 430 million people in the world, mostly in countries where sanitation is poor, and people often walk barefoot.

7 Aug 2018

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

An investigational new drug offers hope of relief for celiac disease patients who are inadvertently exposed to gluten while on a gluten-free diet.

22 May 2018

Study sheds new light on viral replication

Viruses are intracellular parasites that cause disease by infecting the cells in the body and, in a study published today in Nature Microbiology, researchers at Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine showed how a common virus hijacks a host cell's protein to help assemble new viruses before they are released.

13 Mar 2018

Researchers discover mechanism that could open doors to new treatments for celiac disease

Celiac disease is an autoimmune disorder that affects by some estimates nearly 1 in 100 people. Celiac disease symptoms are triggered by gluten, a protein found in wheat and related plants, but gluten doesn't act alone to cause the digestive symptoms that patients suffer.

23 Feb 2018

Study: Diagnosis of celiac disease takes 3.5 years for patients who do not report GI symptoms

It takes an average of 3.5 years to diagnose celiac disease in patients who do not report gastrointestinal symptoms, a Loyola Medicine study has found.

19 Feb 2018

High blood pressure drug may also help prevent onset of type 1 diabetes

A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida in Gainesville.

15 Feb 2018

Celiac Disease News and Research

Latest Celiac Disease News and Research

Gluten, lactose, food dyes in pills could be causing side effects finds study

Fecal transplantation improves the gut of IBS patients

Celiac disease may be caused by gastrointestinal infection in childhood

Gluten-free wheat can be produced for people with celiac disease by using gene editing

Common food additive could cause celiac disease, review says

Study follows children into adolescence to more accurately assess type 1 diabetes risk

World’s first vaccine against coeliac disease to be tested in Australia

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Researchers study how proliferation of gluten-free industry affects people with celiac disease

TU Wien develops new remedy for celiac disease

UGR to coordinate the European H2020 project focused on Smart Personalized Nutrition

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

Major pitfall identified in popular prostate cancer PET imaging method

Research identifies cell signaling pathways related to endocannabinoid system in worms

Researchers identify role of infection-fighting cells in inflamed and damaged tissue

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

Study sheds new light on viral replication

Researchers discover mechanism that could open doors to new treatments for celiac disease

Study: Diagnosis of celiac disease takes 3.5 years for patients who do not report GI symptoms

High blood pressure drug may also help prevent onset of type 1 diabetes

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Celiac Disease News and Research

Latest Celiac Disease News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in